Non-invasively estimate the degree of liver fibrosis in patients with chronic liver diseases such as NAFLD (Non-Alcoholic Fatty Liver Disease) or Hepatitis C. It integrates Age, AST, ALT, and Platelet count to provide an accurate baseline tracking score.
